Lazard Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$137K Sell
7,472
-80,441
-92% -$1.47M ﹤0.01% 1793
2025
Q1
$1.54M Buy
87,913
+16,066
+22% +$281K ﹤0.01% 1053
2024
Q4
$1.24M Buy
71,847
+22,019
+44% +$381K ﹤0.01% 1057
2024
Q3
$927K Buy
49,828
+26,148
+110% +$486K ﹤0.01% 1106
2024
Q2
$364K Buy
+23,680
New +$364K ﹤0.01% 1332
2024
Q1
Sell
-8,475
Closed -$120K 2344
2023
Q4
$120K Buy
8,475
+5,698
+205% +$80.7K ﹤0.01% 1591
2023
Q3
$38K Buy
+2,777
New +$38K ﹤0.01% 1928
2023
Q2
Sell
-2,427
Closed -$27K 2522
2023
Q1
$27K Buy
+2,427
New +$27K ﹤0.01% 1980
2022
Q4
Sell
-2,726
Closed -$35K 2549
2022
Q3
$35K Hold
2,726
﹤0.01% 1934
2022
Q2
$38K Buy
+2,726
New +$38K ﹤0.01% 1928
2021
Q4
Sell
-4,188
Closed -$61K 2439
2021
Q3
$61K Buy
4,188
+181
+5% +$2.64K ﹤0.01% 1592
2021
Q2
$72K Buy
4,007
+2,139
+115% +$38.4K ﹤0.01% 1450
2021
Q1
$32K Buy
1,868
+159
+9% +$2.72K ﹤0.01% 1630
2020
Q4
$29K Sell
1,709
-1,087
-39% -$18.4K ﹤0.01% 1584
2020
Q3
$38K Buy
2,796
+581
+26% +$7.9K ﹤0.01% 1272
2020
Q2
$31K Sell
2,215
-443
-17% -$6.2K ﹤0.01% 1357
2020
Q1
$29K Buy
2,658
+1,599
+151% +$17.4K ﹤0.01% 1366
2019
Q4
$22K Buy
1,059
+418
+65% +$8.68K ﹤0.01% 1209
2019
Q3
$14K Buy
+641
New +$14K ﹤0.01% 1191
2018
Q4
Sell
-7,501
Closed -$173K 1077
2018
Q3
$173K Buy
7,501
+968
+15% +$22.3K ﹤0.01% 886
2018
Q2
$141K Sell
6,533
-383
-6% -$8.27K ﹤0.01% 876
2018
Q1
$122K Sell
6,916
-3,722
-35% -$65.7K ﹤0.01% 886
2017
Q4
$199K Hold
10,638
﹤0.01% 874
2017
Q3
$233K Buy
10,638
+10,358
+3,699% +$227K ﹤0.01% 765
2017
Q2
$6K Buy
+280
New +$6K ﹤0.01% 951
2016
Q1
Sell
-1,383
Closed -$27K 1103
2015
Q4
$27K Hold
1,383
﹤0.01% 957
2015
Q3
$32K Hold
1,383
﹤0.01% 938
2015
Q2
$35K Hold
1,383
﹤0.01% 987
2015
Q1
$45K Hold
1,383
﹤0.01% 976
2014
Q4
$42K Hold
1,383
﹤0.01% 1017
2014
Q3
$33K Hold
1,383
﹤0.01% 934
2014
Q2
$39K Hold
1,383
﹤0.01% 943
2014
Q1
$38K Hold
1,383
﹤0.01% 912
2013
Q4
$36K Hold
1,383
﹤0.01% 918
2013
Q3
$31K Buy
1,383
+200
+17% +$4.48K ﹤0.01% 879
2013
Q2
$30K Buy
+1,183
New +$30K ﹤0.01% 930